NAMPT Inhibitor Market Size, Share & Trends Analysis By Molecule Type (Small Molecules, Biologics), By Line of Treatment (1st Line, 2nd Line), By Indication (Acute Respiratory Distress Syndrome, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma), By Route of Administration (Oral, Intravenous), By Therapeutic Area (Respiratory Disorders, Oncological), by Region, And by Segment Forecasts, 2025-2034